SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-001687
Filing Date
2021-01-21
Accepted
2021-01-21 08:40:24
Documents
14
Period of Report
2021-01-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hrtx-8k_20210121.htm   iXBRL 8-K 35465
2 EX-99.1 hrtx-ex991_6.htm EX-99.1 20523
3 GRAPHIC giee34vxfdeu000001.jpg GRAPHIC 7621
  Complete submission text file 0001564590-21-001687.txt   201263

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20210121.xsd EX-101.SCH 5772
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20210121_lab.xml EX-101.LAB 19480
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20210121_pre.xml EX-101.PRE 11629
7 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-8k_20210121_htm.xml XML 3563
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 21540457
SIC: 2834 Pharmaceutical Preparations